UNVEILING THE CRISIS: THE GLOBAL CHALLENGE OF ANTIBIOTIC DRUG RESISTANCE
Abstract
Antibiotic drug resistance has emerged as a critical global challenge, posing a substantial threat to public health, medical treatments, and healthcare systems worldwide. This paper delves into the multifaceted dimensions of antibiotic drug resistance, encompassing its underlying mechanisms, the factors driving its spread, and the far-reaching consequences it engenders. By analyzing the intricate interplay between microbial evolution, inappropriate antibiotic usage, and the lack of novel drug development, this study aims to shed light on the urgency of addressing this crisis. Furthermore, potential strategies and interventions to mitigate antibiotic drug resistance are explored, emphasizing the collaborative efforts required across medical, governmental, and societal domains. The paper underscores the need for a comprehensive and sustained approach to combat this global challenge, safeguarding the effectiveness of antibiotics for current and future generations.
Similar Articles
-
Experience Of Application Of A New Hemostatic Agent "Gemogubka" In The Prevention Of Bleeding From The Gall Bladder Body After Traditional Cholecystectomy
-
Role Of The PCSF Scale For Patients With Postcovid Syndrome
The American Journal of Medical Sciences and Pharmaceutical Research: No. 7 (2021) / Daminov B.T., Muminov D.K., Davron Kadirovich Muminov, -
REHABILITATION OF PATIENTS AFTER SURGERY WITH POST-COVID ASEPTIC NECROSIS OF THE FEMORAL HEAD
The American Journal of Medical Sciences and Pharmaceutical Research: No. 05 (2023) / Asilova S.U., Mirzaev A., Ernazarov Zh.G., Nazarova F. N., Nazirova M.U., Umarova G.Sh., -
Effective Metods Of Treatment For Chronic Heart Failure In Elderli Women
-
Assessment Of Factors Of Vascular Wall Damage In Depressive Disorders In Patients With Myocardial Infarction
The American Journal of Medical Sciences and Pharmaceutical Research: No. 12 (2020) / Mukhamadieva N.B., -
Brilliant Crisis Medication Instructors Adjust Instructing Techniques To Student Experience Level And Patient Keenness
-
DEVELOPMENT AND VALIDATION OF AN RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF COBICISTAT AND ATAZANAVIR IN BULK AND PHARMACEUTICAL DOSAGE FORM
-
inical And Laboratory Results Of Intrauterine Device Cu T 380 A Intrauterine System Intraoperative Injection
The American Journal of Medical Sciences and Pharmaceutical Research: No. 09 (2020) / Nasirova Zebiniso Azizovna, Negmadjanov Bahodur Boltaevich, -
Communication Of Quality Of Life Indicators, Functional Methods Of Research And Neuromarker BNDF In Patients With Diabetes Mellitus 2 With Diabetic Foot Syndrome
The American Journal of Medical Sciences and Pharmaceutical Research: No. 05 (2021) / Alimkhanov Olimkhon Omilkhonovich, Kamalov Telman Tulyaganovich, -
Today's Dental Diseases And The Causes Of Its Occurrence
The American Journal of Medical Sciences and Pharmaceutical Research: No. 06 (2021) / Abduvakilov Jahongir Ubaydullayevich, Abdurasulov Farrux Abdukarim O’g’li, Shukurov Sherzod Shuxratovich,
References
Drug Resistance at the US National Library of Medicine Medical Subject Headings (MeSH).
Levy SB. From tragedy the antibiotic era is born. In: Levy SB, ed. The Antibiotic paradox: How the Misuse of Antibiotics Destroy Their Curative Power, 2nd ed. Cambridge, MA: Perseus Publishing: 2002.pp.1-14.
Rammelkamp M. Resistances of Staphylococcus aureus to the action of penicillin.Proc R Soc Exp Biol Med 1942:51:386-389.
Jaffe HW. Biddle JW. Johnson SR. Wiesner PJ. Infections due to penicillinases-producing Neisseria gonorrhoeae in the United States: 1976-1980. J Infect Dis 1981; 144:191-197.
Jorgensen JH. Update on mechanisms and prevalence of antimicrobial resistance in Haemophilus influenzae. Clin Infect Dis 1993; 17:1078-1079.
Lowy FD. Medical progress: Staphylococcus aureus infections. N Engl J Med 1998; 339:520-532.
Foster TJ, The Staphylococcus aureus “Superbug”. J Clin Invest 2004; 114:1693-1696.
Espinal MA, Laszlo A, Simonsen L, Boulahbal F, Kim SJ, Reniero A, Hoffner S,Rieder H, Binkin N, Dye C, Williams R, and Raviglione M. Global trends in resistance to antituberculosis drugs. N Engl J Med 2001; 344:1294-1303.
Seppala H, Klaukka T, Lehtonen R, Nenonen E, Huovinen P. Outpatient use of erythromycin: link to introduced erythromycin resistance in Group A streptococci. Clin Infect Dis 1995; 21:1378-1385.
Huovinen P. Macrolide-resistance Group A streptococcus now in the United States. N Engl J Med 2002; 346:1243-1244.
Nuorti JP, Butler JC, Crutcher JM, Guevara R, Welch D, Holder P, Elliot JA. An outbreak of multidrug-resistant pneumococcal pneumonia and bacteremia among unvaccinated nursing home residents. N Engl J Med 1998; 338:1861-1868.
